SAE in mRNA Clinical Trials

This project comprises of the review of the peer reviewed paper, published in Vaccine Journal on 9/2022, that investigates the Serious Adverse Events (SAE) in the Pfizer and Moderna clinical trials prior to the unblinding of the participants.

Our review of the paper is important to the context of our V-Damage project as it establishes a direct link between our analysis of disabilities (using the BLS data) and the original phase III clinical trials for the Covid-19 mRNA vaccines.